Methods for using compositions comprising heat shock proteins or alpha-2-macroglobulin in the treatment of cancer and infectious disease
Details for Australian Patent Application No. 2003223226 (hide)
International Classifications
Event Publications
7 August 2003 Complete Application Filed
Priority application(s): 60/449,001 20.02.03 US
21 October 2004 Application Open to Public Inspection
Published as AU-A-2003223226
1 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
26 June 2008 Section 223(1) Allowances
University of Connecticut Health Center 12 Jun 2008
1 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003223227-A LASER DIODE WITH A LOW ABSORPTION DIODE JUNCTION
2003223225-Compositions and methods for treating epithelial and retinal tissue diseases
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser